Abstract:Protein kinase D (PKD) enzymes play important roles in regulating myocardial contraction, hypertrophy, and remodeling. One of the proteins phosphorylated by PKD is titin, which is involved in myofilament function. In this study, we aimed to investigate the role of PKD in cardiomyocyte function under conditions of oxidative stress. To do this, we used mice with a cardiomyocyte-specific knock-out of Prkd1, which encodes PKD1 (Prkd1loxP/loxP; αMHC-Cre; PKD1 cKO), as well as wild type littermate controls (Prkd1loxP/loxP; WT). We isolated permeabilized cardiomyocytes from PKD1 cKO mice and found that they exhibited increased passive stiffness (Fpassive), which was associated with increased oxidation of titin, but showed no change in titin ubiquitination. Additionally, the PKD1 cKO mice showed increased myofilament calcium (Ca2+) sensitivity (pCa50) and reduced maximum Ca2+-activated tension. These changes were accompanied by increased oxidation and reduced phosphorylation of the small myofilament protein cardiac myosin binding protein C (cMyBPC), as well as altered phosphorylation levels at different phosphosites in troponin I (TnI). The increased Fpassive and pCa50, and the reduced maximum Ca2+-activated tension were reversed when we treated the isolated permeabilized cardiomyocytes with reduced glutathione (GSH). This indicated that myofilament protein oxidation contributes to cardiomyocyte dysfunction. Furthermore, the PKD1 cKO mice exhibited increased oxidative stress and increased expression of pro-inflammatory markers interleukin (IL)-6, IL-18, and tumor necrosis factor alpha (TNF-α). Both oxidative stress and inflammation contributed to an increase in microtubule-associated protein 1 light chain 3 (LC3)-II levels and heat shock response by inhibiting the mammalian target of rapamycin (mTOR) in the PKD1 cKO mouse myocytes. These findings revealed a previously unknown role for PKD1 in regulating diastolic passive properties, myofilament Ca2+ sensitivity, and maximum Ca2+-activated tension under conditions of oxidative stress. Finally, we emphasized the importance of PKD1 in maintaining the balance of oxidative stress and inflammation in the context of autophagy, as well as cardiomyocyte function.

Cyclophilin D Regulates Mitochondrial Flashes and Metabolism in Cardiac Myocytes.

Downregulation Of Cypher Induces Apoptosis In Cardiomyocytes Via Akt/P38 Mapk Signaling Pathway

Mitochondrial flashes regulate ATP homeostasis in the heart.

Mitochondrial fission process 1 (MTFP1) controls bioenergetic efficiency and prevents inflammatory cardiomyopathy and heart failure in mice

Cyclophilin D: Guardian or Executioner for Tumor Cells?

Cyclophilin D as a drug target

Mitoflash altered by metabolic stress in insulin-resistant skeletal muscle

Remodeling Of Mitochondrial Flashes In Muscular Development And Dystrophy In Zebrafish

Protein Kinase D Plays a Crucial Role in Maintaining Cardiac Homeostasis by Regulating Post-Translational Modifications of Myofilament Proteins

Phosphorylations and Acetylations of Cytochrome c Control Mitochondrial Respiration, Mitochondrial Membrane Potential, Energy, ROS, and Apoptosis

Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death

A defect in mitochondrial protein translation influences mitonuclear communication in the heart

Cardiac CIP protein regulates dystrophic cardiomyopathy

The cyclophilin D (CypD) of Toxoplasma gondii is involved in the parasite's response to oxidative stress damage

PGC-1 Alpha Regulates Expression of Myocardial Mitochondrial Antioxidants and Myocardial Oxidative Stress after Chronic Systolic Overload.

Cyclophilin D plays a critical role in the survival of senescent cells

Regulation of Mitoflash Biogenesis and Signaling by Mitochondrial Dynamics

Mitoflash Biogenesis and Its Role in the Autoregulation of Mitochondrial Proton Electrochemical Potential

Activation of cardiac Cdk9 represses PGC-1 and confers a predisposition to heart failure

N-terminal cleavage of cyclophilin D boosts its ability to bind F-ATP synthase

Abstract 19529: FUNDC1 Deficiency Exacerbates Pathological Cardiac Remodeling and Contractile Dysfunction Through Suppression of DRP1